FDA approved Lilly’s Jaypirca as a first treatment for adults with CLL or SLL without 17p deletion. Here are the trial results, side effects, and costs.
Adults Newly Facing Leukemia Treatment Gain Another Pill Option as FDA Clears Jaypirca for Untreated CLL
by | Oct 4, 2026 | Uncategorized | 0 comments
Recent Comments